Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.

Ontario health technology assessment series - 1 Jan 2020

Abstract excerpt

BACKGROUND: RhD blood group incompatibility during pregnancy can cause serious health problems for the fetus. Noninvasive fetal RhD blood group genotyping is a test for fetal RhD status that may help prevent unnecessary preventive treatment (Rh immunoglobulin [RhIG] injections) and intensive pregnancy monitoring. We conducted a health technology assessment of noninvasive fetal RhD blood group genotyping for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Group Antigens
Share to Cost-Benefit Analysis
Share to Ontario

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pregnancy Complications

Share to Quality-Adjusted Life Years

Share to Quality of Life

Share to Rh-Hr Blood-Group System

Share to Rh Isoimmunization

Source

Open in PubMed Open full text

Identifiers

PMID: 33240456
PMCID: PMC7670296

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.PMID 33240456Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations.Semantic proximity Read ↗

Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies.Semantic proximity Read ↗

Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted ProphylaxisSemantic proximity Read ↗

Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.Semantic proximity Read ↗

Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysisSemantic proximity Read ↗

[Sensitivity and specificity of noninvasive prenatal fetal RhD genotesting: a meta-analysis].Semantic proximity Read ↗

Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.Semantic proximity Read ↗

High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.Semantic proximity Read ↗

Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.Semantic proximity Read ↗

Noninvasive fetal blood group antigen genotyping.Semantic proximity Read ↗

Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.